Effects of the selective delta opioid agonist SNC80 on cocaine- and food-maintained responding in rhesus monkeys

European Journal of Pharmacology

Volumn 547, Issue 1-3, 2006, Pages 92-100

  Do Carmo, Gail Pereira ^a   Mello, Nancy K ^a   Rice, Kenner C ^b   Folk, John E ^a   Negus, S Stevens ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

(Rhesus monkey); Cocaine self administration; Delta opioid receptor agonist; SNC80

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; COCAINE; DELTA OPIATE RECEPTOR AGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; DRUG EFFECT; DRUG SELECTIVITY; DRUG SELF ADMINISTRATION; FEMALE; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOOD; MACACA MULATTA; MALE; PIPERAZINES; RECEPTORS, OPIOID, DELTA; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; TIME FACTORS;

EID: 33748528634     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.075     Document Type: Article

References (57)

1. Bilsky E.J., Calderon S.N., Wang T., Bernstein R.N., Davis P., Hruby V.J., McNutt R.W., Rothman R.B., Rice K.C., and Porreca F. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J. Pharmacol. Exp. Ther. 273 (1995) 359-366
2. Bowen C.A., Negus S.S., Zong R., Neumeyer J.L., Bidlack J.M., and Mello N.K. Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys. Neuropsychopharmacology 28 (2003) 1125-1139
3. Brandt M.R., Negus S.S., Mello N.K., Furness M.S., Zhang X., and Rice K.C. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys. J. Pharmacol. Exp. Ther. 290 (1999) 1157-1164
4. Brandt M.R., Furness M.S., Rice K.C., Fischer B.D., and Negus S.S. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. J. Pharmacol. Exp. Ther. 299 (2001) 629-637
5. Brandt M.R., Furness M.S., Mello N.K., Rice K.C., and Negus S.S. Antinociceptive effects of delta-opioid agonists in rhesus monkeys: effects on chemically induced thermal hypersensitivity. J. Pharmacol. Exp. Ther. 296 (2001) 939-946
6. Caine S.B., Negus S.S., and Mello N.K. Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology (Berl.) 148 (2000) 41-51
7. Calderon S.N., Rothman R.B., Porreca F., Flippen-Anderson J.L., McNutt R.W., Xu H., Smith L.E., Bilsky E.J., Davis P., and Rice K.C. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. J. Med. Chem. 37 (1994) 2125-2128
8. Carroll F.I., Howell L.L., and Kuhar M.J. Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J. Med. Chem. 42 (1999) 2721-2736
9. Devine D.P., and Wise R.A. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14 (1994) 1978-1984
10. Devine D.P., Leone P., Pocock D., and Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266 (1993) 1236-1246
11. de Vries T.J., Babovic-Vuksanovic D., Elmer G., and Shippenberg T.S. Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine. Psychopharmacology (Berl.) 120 (1995) 442-448
12. Di Chiara G., and Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244 (1988) 1067-1080
13. Duvauchelle C.L., Fleming S.M., and Kornetsky C. DAMGO and DPDPE facilitation of brain stimulation reward thresholds is blocked by the dopamine antagonist cis-flupenthixol. Neuropharmacology 36 (1997) 1109-1114
14. Fraser G.L., Pradhan A.A., Clarke P.B., and Wahlestedt C. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat. J. Pharmacol. Exp. Ther. 295 (2000) 1135-1141
15. Glowa J.R., and Fantegrossi W.E. Effects of dopaminergic drugs on food- and cocaine-maintained responding, IV. Continuous cocaine infusions. Drug Alcohol Depend. 45 (1997) 71-79
16. Glowa J.R., Wojnicki F.H.E., Matecka D., Bacher J.D., Mansbach R.S., Balster R.L., and Rice K.C. Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine. Exp. Clin. Psychopharmacol. 3 (1995) 219-231
17. Glowa J.R., Wojnicki F.H.E., Matecka D., Bacher J.D., Mansbach R.S., Balster R.L., and Rice K.C. Effects of dopamine uptake inhibitors on food- and cocaine-maintained responding: II. Comparisons with other drugs and repeated administration. Exp. Clin. Psychopharmacol. 3 (1995) 232-239
18. Glowa J.R., Fantegrossi W.E., Lewis D.B., Matecka D., Rice K.C., and Rothman R.B. Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909. J. Med. Chem. 39 (1996) 4689-4691
19. Goeders N.E., Lane J.D., and Smith J.E. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20 (1984) 451-455
20. Grabowski J., Shearer J., Merrill J., and Negus S.S. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict. Behav. 29 (2004) 1439-1464
21. He L., and Lee N.M. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J. Pharmacol. Exp. Ther. 285 (1998) 1181-1186
22. Jutkiewicz E.M., and Woods J.H. Antidepressant-like effects in delta opioid receptor agonists. In: Chang K., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, Inc., New York/Basel 355-372
23. Ko M.C., Lee H., Harrison C., Clark M.J., Song H.F., Naughton N.N., Woods J.H., and Traynor J.R. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys. J. Pharmacol. Exp. Ther. 306 (2003) 179-186
24. Kuhar M.J., Ritz M.C., and Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14 (1991) 299-302
25. Longoni R., Spina L., Mulas A., Carboni E., Garau L., Melchiorri P., and Di Chiara G. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J. Neurosci. 11 (1991) 1565-1576
26. Maisonneuve I.M., Archer S., and Glick S.D. U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci. Lett. 181 (1994) 57-60
27. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7 (1987) 2445-2464
28. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., and Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350 (1994) 412-438
29. Mello N.K., and Negus S.S. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14 (1996) 375-424
30. Mello N.K., and Negus S.S. Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. J. Pharmacol. Exp. Ther. 286 (1998) 812-824
31. Mello N.K., and Negus S.S. Interactions between kappa opioid agonists and cocaine. Preclinical studies. Ann. N. Y. Acad. Sci. 909 (2000) 104-132
32. Mello N.K., Lukas S.E., Kamien J.B., Mendelson J.H., Drieze J., and Cone E.J. The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J. Pharmacol. Exp. Ther. 260 (1992) 1185-1193
33. Mendelson J.H., and Mello N.K. Management of cocaine abuse and dependence. N. Engl. J. Med. 334 (1996) 965-972
34. Meyer M.E. Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities. Pharmacol. Biochem. Behav. 45 (1993) 315-320
35. Narita M., and Suzuki T. Delta opioid receptor-mediated antinociception/analgesia. In: Chang K., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, Inc., New York/Basel 331-354
36. Negus S.S. Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology 28 (2003) 919-931
37. Negus S.S. Delta opioids and substance abuse. In: Chang K., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, Inc., New York/Basel 401-430
38. Negus S.S., and Mello N.K. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy. J. Pharmacol. Exp. Ther. 300 (2002) 1111-1121
39. Negus S.S., and Mello N.K. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology (Berl.) 167 (2003) 324-332
40. Negus S.S., and Mello N.K. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend. 70 (2003) 39-52
41. Negus S.S., and Mello N.K. Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend. 74 (2004) 297-309
42. Negus S.S., Mello N.K., Portoghese P.S., Lukas S.E., and Mendelson J.H. Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 273 (1995) 1245-1256
43. Negus S.S., Mello N.K., Portoghese P.S., and Lin C.E. Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J. Pharmacol. Exp. Ther. 282 (1997) 44-55
44. Negus S.S., Gatch M.B., Mello N.K., Zhang X., and Rice K. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J. Pharmacol. Exp. Ther. 286 (1998) 362-375
45. Ossipov M.H., Lai J., Vanderah T.W., and Porreca F. The delta receptor subtypes and pain modulation. In: Chang K., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, Inc., New York/Basel 297
46. Rothman R.B., and Glowa J.R. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909. Mol. Neurobiol. 11 (1995) 1-19
47. Rowlett J.K., and Spealman R.D. Opioid enhancement of the discriminative stimulus effects of cocaine: evidence for involvement of mu and delta opioid receptors. Psychopharmacology (Berl.) 140 (1998) 217-224
48. SAMHSA, 2004. Results from the 2003 National Survey on Drug Abuse and Health: National findings, (Office of Applied Studies, NSDUH Series H-25 DHHS Publication No. SMA 04-3964). Rockville, MD.
49. Shippenberg T.S., Bals-Kubik R., and Herz A. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res. 436 (1987) 234-239
50. Sofuoglu M., and Kosten T.R. Novel approaches to the treatment of cocaine addiction. CNS Drugs 19 (2005) 13-25
51. Spanagel R., Herz A., and Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55 (1990) 1734-1740
52. Spanagel R., Herz A., and Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 2046-2050
53. Stevenson G.W., Wentland M.P., Bidlack J.M., Mello N.K., and Negus S.S. Effects of the mixed-action kappa/mu opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeys. Eur. J. Pharmacol. 506 (2004) 133-141
54. Suzuki T., Mori T., Tsuji M., Maeda J., Kishimoto Y., Misawa M., and Nagase H. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Eur. J. Pharmacol. 324 (1997) 21-29
55. Ukai M., Mori E., and Kameyama T. Cocaine-like discriminative stimulus properties of the delta-selective opioid receptor agonist, [D-Pen2, L-Pen5]enkephalin, in the rat. Eur. J. Pharmacol. 231 (1993) 143-144
56. Vocci F., and Ling W. Medications development: successes and challenges. Pharmacol. Ther. 108 (2005) 94-108
57. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend. 51 (1998) 13-22